Kazia Therapeutics announced a transaction from Sydney, led by CEO Dr. John Friend.
8 reports, 2 independent
Updated Aug 1
Gone quiet
- Reports
- 8
- Developments
- 1
- Repetition
- 88%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Kazia Therapeutics announced a transaction from Sydney, led by CEO Dr. John Friend.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Kazia Therapeutics (Australia)
company in Sydney, Australia
Nothing else this week.
-
John Friend
American yoga teacher
Nothing else this week.
Coverage
Newest first; wire copies grouped- manilatimes.net
- PR NewswireKazia Therapeutics Announces $2 Million Private Placement at Premium to Market SYDNEY, Aug. 1, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development com
- Unknown outlet